Across pharmaceuticals, biotechnology, technology, consumer goods and private capital. Six have been acquired or sold to private equity.
One of the world’s leading manufacturers of aseptic and terminally sterilized injectable medications. BPI set new standards in pharmaceutical production — the unglamorous manufacturing rigour that every therapy downstream quietly depends on.
Pioneered novel therapeutics including a preservative-free Epinephrine and Ablysinol, an orphan drug for cardiac use. Belcher’s work is a study in finding the therapies nobody else would reformulate, and doing it properly.
A biopharma company that reshaped the wound care market with proprietary sterilized Type II collagen dressings. Acquired within four years of inception.
An industry leader in regenerative care, specialising in the development, manufacture and commercialisation of cell therapies and human cellular and tissue-based products — including perinatal mesenchymal stem cells (MSC) and exosomes.
A CRO focused on the development of niche and novel therapeutics via the FDA 505(b)(2) regulatory pathway. Castun has been awarded several FDA approvals, since licensed off.
A Brazil-based sterile injectable manufacturer of peptide-based products, sold directly to consumers and healthcare providers.
A pharmaceutical consultancy focused on the acquisition, licensing and sale of distressed and underperforming drug assets — value recovered from molecules other operators had written off.
One of the largest sterile 503A compounding pharmacies in the country, specialising in longevity, ophthalmics and animal health. Acquired by a private equity firm.
A specialty generic pharmaceutical company commercialising niche therapeutics. Considered one of the fastest-growing generic pharmaceutical companies of its cohort, and sold to private equity within five years of inception.
A GovTech business, and one of the first cloud-based SaaS public safety platforms — 911 dispatch and records management for agencies that had been running on decades-old systems. Sold to private equity within four years.
An IT managed services provider covering infrastructure, co-location and virtual hosting. Ace is a leader in streaming services, AI, blockchain and crypto hosting.
A healthcare consultancy delivering solutions across pharmaceuticals, biotechnology and the medical sector. Its integrated approach combines science, technology and commercialisation to create sustainable value.
A family-owned vineyard in Napa Valley producing some of the most esteemed award-winning Cabernet Sauvignon in the valley.
A bioscience company pioneering the use of Raman spectroscopy for the non-invasive testing of analytes. Kaligia created the first non-blood test for A1C and blood sugar; the intellectual property portfolio was subsequently divested.
One of the largest contract manufacturers of nutraceutical and skincare products in the United States. Acquired within three years.
A pioneer in the functional food space, BEN launched the first protein, zero-carbohydrate chip — a category that barely existed at the time. Acquired within five years.
A NASDAQ-listed, multi-faceted healthcare company specialising in pharmaceutical contract manufacturing and pharmacy benefit management services.
A family office and diversified holding company dedicated to managing private capital and an investment portfolio spanning oil and gas, real estate, aircraft and sports entertainment.
Select any venture above to read its full description. 18 total. Founding and exit dates are not published for these companies.